home / stock / syk / syk articles

SYK Articles, Stryker Corporation

Stock Information
Company Name: Stryker Corporation
Stock Symbol: SYK
Market: NYSE
Website: stryker.com
Menu
SYK SYK Quote SYK Short SYK News SYK Articles SYK Message Board
Get SYK Alerts

News, Short Squeeze, Breakout and More Instantly...
$100 Invested In Stryker 10 Years Ago Would Be Worth This Much Today | Benzinga

Stryker (NYSE:SYK) has outperformed the market over the past 10 years by 4.28% on an annualized basis producing an average annual return of 15.2%. ...
$1000 Invested In Stryker 15 Years Ago Would Be Worth This Much Today | Benzinga

Stryker (NYSE:SYK) has outperformed the market over the past 15 years by 3.14% on an annualized basis producing an average annual return of 15.27%....

Stryker Stock Is Attractive Considering Its Double-Digit Organic Revenue Growth - Analyst Upgrades Stock | Benzinga

Needham analyst Mike Matson upgraded Stryker Corp (NYSE:SYK) from Hold to Buy and a $392 price target. Matson expects new ...

This Kraft Heinz Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Here's How Much You Would Have Made Owning Stryker Stock In The Last 10 Years | Benzinga

Stryker (NYSE:SYK) has outperformed the market over the past 10 years by 4.41% on an annualized basis producing an average annual return of 15.21%....

$1000 Invested In This Stock 20 Years Ago Would Be Worth $6,600 Today | Benzinga

Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.91% on an annualized basis producing an average annual return of 9.83%. ...

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week | Benzinga

Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. As we look ahead to the unfolding week, it r...
Boston Scientific (BSX) Faces Rising Costs, Competition | Benzinga

Boston Scientific Corporation (NYSE: BSX) has been struggling due to unfavorable currency movement and macroeconomic woes. Strong competitors in th...

Globus Medical (GMED) Gains From New Launches Amid Macro Issues | Benzinga

Globus Medical (NYSE: GMED) continues to gain from surging demand for its Musculoskeletal Solutions products. Meanwhile, the company is expanding i...

Price Over Earnings Overview: Stryker | Benzinga

In the current session, the stock is trading at $351.79, after a 0.63% spike. Over the past month, Stryker Inc. (NYSE:SYK) stock increased by 1.24%...
Next 10